000 | 01553 a2200421 4500 | ||
---|---|---|---|
005 | 20250517133320.0 | ||
264 | 0 | _c20170508 | |
008 | 201705s 0 0 eng d | ||
022 | _a1476-5462 | ||
024 | 7 |
_a10.1038/gt.2017.3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMølgaard, K | |
245 | 0 | 0 |
_aBalanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity. _h[electronic resource] |
260 |
_bGene therapy _c04 2017 |
||
300 |
_a208-214 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntibodies, Bispecific _xgenetics |
650 | 0 | 4 |
_aCD3 Complex _xgenetics |
650 | 0 | 4 |
_aCarcinoembryonic Antigen _ximmunology |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 |
_aFoot-and-Mouth Disease Virus _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aJurkat Cells |
650 | 0 | 4 |
_aLymphocyte Activation _ximmunology |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aPeptides _xgenetics |
650 | 0 | 4 |
_aSingle-Chain Antibodies _xgenetics |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTumor Necrosis Factor Receptor Superfamily, Member 7 _xgenetics |
700 | 1 | _aCompte, M | |
700 | 1 | _aNuñez-Prado, N | |
700 | 1 | _aHarwood, S L | |
700 | 1 | _aSanz, L | |
700 | 1 | _aAlvarez-Vallina, L | |
773 | 0 |
_tGene therapy _gvol. 24 _gno. 4 _gp. 208-214 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/gt.2017.3 _zAvailable from publisher's website |
999 |
_c26773043 _d26773043 |